Evidence map›Paper›PMID 36341041›Full record

ArticleIJID regions2022

Prevalence of occult hepatitis B virus infection among patients receiving haemodialysis in Sana'a city.

Bodoor Ali Hussen Al-Masoodi, Alariqi Reem, Saleh S Bahaj, Raja M Al-Haimi, Hassan A Al-Shamahy, Nagib Abuasba, Abdu-Raoof Mohammad Al-Shawkany, Jay Prakash Prasad Kumal

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJID regions, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Bodoor Ali Hussen Al-MasoodiMedical Laboratory Department, Faculty of Medical Sciences, Sana'a University, Sana`a, Yemen.
Alariqi ReemMedical Laboratory Department, Faculty of Medical Sciences, Sana'a University, Sana`a, Yemen.
Saleh S BahajMedical Laboratory Department, Faculty of Medical Sciences, Sana'a University, Sana`a, Yemen.
Raja M Al-HaimiMedical Laboratory Department, Faculty of Medical Sciences, Sana'a University, Sana`a, Yemen.
Hassan A Al-ShamahyMedical Laboratory Department, Faculty of Medical Sciences, Sana'a University, Sana`a, Yemen.
Nagib AbuasbaMedical Laboratory Department, Faculty of Medical Sciences, Sana'a University, Sana`a, Yemen.
Abdu-Raoof Mohammad Al-ShawkanyCollege of Veterinary Medicine, Sana`a University, Sana`a, Yemen.
Jay Prakash Prasad KumalJanaki Medical College and Teaching Hospital, Ramdaiya Bhawadi, Janakpurdham, Nepal.
Sana'a University · YEJanaki Medical College

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Occult hepatitis B virus infection (OBI) is a challenging entity. Due to the increase in invasive procedures, blood transfusions, and difficulties in diagnosing OBI, patients are more likely to acquire OBI. This cross-sectional study was conducted to assess the prevalence of OBI by hepatitis B virus (HBV)-DNA detection, the prevalence of HBV infection by total hepatitis B core antibody (HBcAb) detection, and the potential risk factors for HBV infection in patients receiving haemodialysis regularly. Methods: This study included 80 patients receiving haemodialysis regularly, without acute or chronic HBV infection. They were selected from the dialysis units in Sana'a city, Yemen from June 2016 to June 2017. Patients who were positive for hepatitis B surface antigen and hepatitis B surface antibody were excluded from this study. Blood samples were taken prior to each haemodialysis session, and serological markers of HBV were included. HBcAb was measured by enzyme-linked immunosorbent assay, and HBV-DNA was measured by polymerase chain reaction. Results: HBV-DNA was detected in four patients (5%) and HBcAb was detected in 38 patients (47.5%). There was a significant association between HBV-DNA and HBcAb in patients receiving haemodialysis regularly. Conclusions: Patients who test positive for HBcAb should undergo additional HBV-DNA testing to allow accurate HBV screening and prevent infection of other patients.

Indexed as

Conventional PCRHaemodialysis patientsHBVOccult hepatitis B virusSana'a city

Identifiers

PMID36341041
PMCPMC9634008
OpenAlexW4296518760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.